Celltrion Healthcare IPO To Accelerate Celltrion's Global Biosimilar Expansion

Celltrion Healthcare's initial public offering, which is seen as the most anticipated biotech IPO in South Korea's Kosdaq market this year, is set to speed up Celltrion's expansion of its global market presence as well as the development of biosimilars and novel drugs.

Money Wave

Celltrion Healthcare Co. Ltd. has successfully completed a KRW1tn ($889.3m) IPO in South Korea's second-tier Kosdaq market, paving the way for the company to further expand its global sales networks and product portfolios.

Celltrion Healthcare, which is the global marketing and distribution arm of Celltrion Inc., has exclusive sales rights to Celltrion's...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip